Advanced Search


Study ID Status Title Patient Level Data
115902 Completed A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin from Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects with Acne Vulgaris Study Listed on
115912 Completed A multi-center, open-label study of GSK548470 (Tenofovir Disoproxil Fumarate) in patients with compensated chronic hepatitis B with poor response to other drugs
115918 Completed An open-label study to assess the immunogenicity and safety of GSK Biologicals’ hepatitis B vaccine, Engerix™-B in adults with or without type 2 diabetes mellitus Study Listed on
115919 Terminated An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with mild to moderate systemic lupus erythematosus Study Listed on
115921 Completed A Double-blind, Randomised, Placebo-controlled Study to Investigate the Efficacy and Safety of Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Subjects Receiving Standard of Care Therapy
115926 Completed Drug Use Investigation for ROTARIX
115927 Completed Special Drug Use Investigation for ROTARIX
115938 Completed A multi-center, randomized, double-blind, dose-ranging study to evaluate GSK573719 in combination with fluticasone furoate, fluticasone furoate alone, and an active control of fluticasone furoate/vilanterol combination in subjects with asthma Study Listed on
115951 Completed A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects with Mild to Moderate Ulcerative Colitis Study Listed on
115954 Completed Evaluation of pharmaceutical bioequivalence of Amoxicillin trihydrate - Clamoxyl 500mg/5mL (Glaxo Wellcome Production.) in the form powder for oral suspension versus Amoxil ® 500mg/5mL (GlaxoSmithKline Mexico SA) in the form of powder for oral suspension in healthy volunteers and fasting, using techniques of Liquid Chromatography
115959 Completed A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid after Topical Administration of GSK2585823 in Japanese Subjects with Acne Vulgaris Study Listed on
115960 Relinquished An Open-Label, Dose Escalation, Phase I Study to Evaluate the Tolerability, Safety and Pharmacokinetics of Afuresertib Monotherapy and in Combination with Bortezomib and Dexamethasone in Japanese Relapsed Multiple Myeloma Patients
115970 Not yet recruiting An observational, non-interventional study for the follow-up of subjects receiving GSK2398852
115981 Terminated A post marketing surveillance study to monitor the risk of urinary retention in retigabine users
115983 Completed Rechallenge Analysis: Detection of Potential Drug-Induced Liver Injury using Kaiser California Database
115984 Completed Phase 1 Study of the BRAF inhibitor dabrafenib +/- MEK inhibitor trametinib in combination with ipilimumab for unresectable or metastatic melanoma
115991 Relinquished A Phase II, Multi-centre Study Investigating the Safety and Efficacy of Ofatumumab and Bendamustine Combination in Patients with Untreated or Relapsed Chronic Lymphocytic Leukaemia (CLL)
115992 Completed Two-dose primary vaccination with either GSK Biologicals' 10-valent pneumococcal vaccine (Synflorix™) or Pfizer’s Prevenar 13™ or both vaccines followed by a booster dose of Synflorix™
115997 Completed Effect of influenza vaccine against mismatched strains: Systematic Review
116008 Completed A randomized, placebo-controlled, study to evaluate the effects of GSK1278863A on pulmonary artery pressure in healthy volunteers Study Listed on
116010 Completed A Phase I, Open-label, Three-Period, Single Sequence, Crossover Study Evaluating the Drug-Drug Interaction Between Eltrombopag and Boceprevir and Between Eltrombopag and Telaprevir in Healthy Adult Subjects
116013 Relinquished Phase I/IIa, 2-Part, Multi-Center, Single-Arm, Open-Label Study to Determine the Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V600-Mutation Positive Solid Tumors
116015 Completed WEUKBRE5716: Quantifying the burden of steroid-related damage in systemic lupus erythematosus in the Hopkins Lupus Cohort
116018 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Non-typeable Haemophilus influenzae (NTHi) investigational vaccine (GSK2838497A) in healthy adults
116021 Completed A study to assess immunity to specific microbial antigens in healthy smokers and non-smokers and in subjects with stable Chronic Obstructive Pulmonary Disease (COPD) aged between 45-75 years



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.